Circius Pharma ApS: Financial statements 2025
CVR: 42447641
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Circius Pharma ApS (CVR 42447641) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,858,282 and a net result of DKK 0 compared with DKK 0 the year before. That is an increase of 4% compared with the year before. Equity in the 2025 report amounted to DKK 3,437,320. The solvency ratio was 63.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,858,282
- Profit/Loss
- DKK 0
- Equity
- DKK 3,437,320
- Total Assets
- DKK 5,417,023
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.9 mio. | 0 | 3.4 mio. | 2 |
| 2024 | - | 2.7 mio. | 0 | 3.4 mio. | 2 |
| 2023 | - | 2.8 mio. | -2.2 mio. | 3.4 mio. | 2 |
| 2022 | - | 2.8 mio. | -16 t. | 5.7 mio. | 2 |
Official annual report
How creditworthy is Circius Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Circius Pharma ApS has published its annual report for 2024. Gross profit came to DKK 2,749,398, and the net result was DKK 0.
About Circius Pharma ApS
Circius Pharma ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Erik Gustav Smith, Jan Gustav Smith and Johan Lindberg. The company is owned by Circius Pharma AB. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,858,282 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 3,437,320.